Status:
UNKNOWN
Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes
Lead Sponsor:
Makerere University
Collaborating Sponsors:
Swedish International Development Cooperation Agency (SIDA)
Conditions:
Fetal Distress
Birth Asphyxia
Eligibility:
FEMALE
Phase:
PHASE3
Brief Summary
Introduction Birth asphyxia is one of leading causes of neonatal mortality in Uganda. It is associated with long term neuro-developmental complications among the babies that survive. Preventive measur...
Detailed Description
Background: Foetal distress which refers to fetal heart rate of less than 120 or more than 160 beats per minute(Pildner von Steinburg et al., 2013) during labour is one of the contributing factors to...
Eligibility Criteria
Inclusion
- Women in active first stage of labor who develop fetal distress will be included
Exclusion
- Women in labor with critical conditions such as eclampsia, chronic heart disease, chronic lung disease and chronic renal failure
- Women in preterm labor
- Those taking Bleomycin and Amiodarone medications
Key Trial Info
Start Date :
March 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2020
Estimated Enrollment :
1108 Patients enrolled
Trial Details
Trial ID
NCT04043299
Start Date
March 16 2020
End Date
October 30 2020
Last Update
March 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kawempe National Referral Hospital
Kampala, Uganda, 256